NICE NG28: A Major First-Line Shift The most significant structural change in NICE NG28s February 2026 update: metformin combined with an SGLT-2 inhibitor is now the standard first-line therapy for virtually all adults with type 2 diabetes, regardless of comorbidities
It works by strengthening the skins own antioxidant ecosystem, a process that is gradual, biological, and dependent on consistency rather than quick fixes
Site rotation is essential to prevent lipohypertrophy, which can impair drug absorption and reduce therapeutic effect
Similar to all GLP-1 RA medications and due to the mechanism of the drug, Rybelsus reduces gut motility (this is usually what make people feel fuller faster), and mild to moderate stomach upset and/or nausea may occur
Erythrocyte glutathione and serum glutathione-S-transferase in research subjects with [PMID: 12809743] Laboratory literature summary: Erythrocyte glutathione and serum glutathione-S-transferase in research subjects with brain tumors
That list sits alongside its broader point that selection should be a single-agent decision made with a clinician rather than a self-assembled combination